Fig. 3From: Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trialEfficacy CAR. Proportion of participants who reported abstinence from vaping, which was defined by cotinine level-verified self-reported abstinence. Primary efficacy end point was the continuous abstinence rate at weeks 4 to 12Back to article page